CXCR5 and nasopharyngeal carcinoma: Therefore, we divided the NPC patients into CXCL13-high and CXCL13-low groups based on the median gene expression, and observed that the fraction of the CXCR5+ B cells was significantly higher in CXCL13-high patients (Fig. 3e).